Evidence map›Paper›PMID 41878523›Full record

ArticleFrontiers in oncology2026

Dual-modality CAD for breast cancer screening: dealing with discordant diagnosis between mammography and tomography.

Hubert Beaumont, Antoine Iannessi, Thomas Louis, Serena Pacile, Pierre Fillard

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hubert BeaumontIndependent Researcher, Valbonne, France.
Antoine IannessiIndependent Researcher, Valbonne, France.
Thomas LouisTherapixel, Paris, France.
Serena PacileTherapixel, Paris, France.
Pierre FillardTherapixel, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Full-field digital mammography (FFDM) is the standard for breast cancer screening. Digital breast tomosynthesis (DBT), compared to FFDM, enhances cancer detection and reduces unnecessary biopsies. Despite DBT's adoption, critical questions remain-higher radiation, time, cost, and clinical benefits, particularly for systematic breast screening. In the era of AI computer-aided detection/diagnosis (CAD) for breast screening, one unresolved question is the role of bimodal algorithms in predicting cancer and offering guidance when opinions differ, and we aim to understand this. Methods: We retrospectively assembled an enriched screening cohort of 1,816 women who underwent both FFDM and DBT at two Hologic sites. Analyses requiring paired CAD scores were performed on a lesion-level subset for which both FFDM and DBT CAD scores were available (low suspicion = 1; high suspicion = 10) and reference standard outcomes were known, comprising 1,071 lesions from 657 examinations. From the joint distribution, we defined areas of "perpendicular scoring" (PS) as the areas of highly discordant scoring. We estimated the inter-modality agreement using the three classes (low, indeterminate, and high suspicious) with Cohen's kappa index. We evaluated the potential of systematic, lossless, and AI-powered reclassifications of PS both for tumoral masses and calcifications and in considering breast density as a risk factor for PS. Results: We observed a moderate inter-modality agreement, indicated by a kappa of 0.49 (95% CI: 0.46-0.52). PS scoring was present in 32.7% (95% CI: 29.7-35.8) of tumoral masses (soft tissue lesion) cases and 38.6% (95% CI: 30.1-47.6) of calcification cases. Breast density was a risk factor of PS for masses (odd, 0.66 [95% CI: 0.48-0.91]). AI-powered and lossless models were found effective for reclassifying 82.2% and 67.3% of PS of masses and calcification, respectively. Conclusions: When processed by CAD, FFDM and DBT provided complementary information at the expense of unavoidable discordant diagnosis. Post-processing has the potential of reclassifying part of the discordant diagnosis in improving the overall performance of the CAD. Therefore, exploring alternative reclassification methods is essential.

Indexed as

breast neoplasmscomputer-assistedmammographymass screeningreproducibility of results

Identifiers

PMID41878523
PMCPMC13006242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.